Phenotypes, genotypes, serotypes and molecular epidemiology of erythromycin-resistant Streptococcus agalactiae in Italy

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 31, Issue 8, 2012, Pages 1741-1747

  De Francesco, M A ^a   Caracciolo, S ^a   Gargiulo, F ^a   Manca, N ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA LIKE PROTEIN; CLINDAMYCIN; ERYTHROMYCIN; MACROLIDE; MEMBRANE PROTEIN; PENICILLIN G; PROTEIN; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; CLONAL VARIATION; GENOTYPE; ITALY; MOLECULAR EPIDEMIOLOGY; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FAMILY; SEROTYPE; STREPTOCOCCUS AGALACTIAE; URINALYSIS; VAGINA;

ADULT; AGED; ANTI-BACTERIAL AGENTS; CLUSTER ANALYSIS; DRUG RESISTANCE, BACTERIAL; ERYTHROMYCIN; FEMALE; GENES, BACTERIAL; GENOTYPE; HUMANS; ITALY; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; PHENOTYPE; PREGNANCY; PREVALENCE; SEROTYPING; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; URINE; VAGINA; VIRULENCE FACTORS;

EID: 84866408998     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-011-1495-4     Document Type: Article

References (39)

1. Baker CJ (2000) Group B streptococcal infections. In: Stevens DL, Kaplan EL (eds) Streptococcal infections: clinical aspects, microbiology, and molecular pathogenesis. Oxford University Press, New York, pp 222-237
2. Acikgoz ZC, Almayanlar E, Gamberzade S, Gocer S (2004) Macrolide resistance determinants of invasive and noninvasive group B streptococci in a Turkish hospital. Antimicrob Agents Chemother 48:1410-1412 (Pubitemid 38405507)
3. Borchardt SM, DeBusscher JH, Tallman PA, Manning SD, Marrs CF, Kurzynski TA, Foxman B (2006) Frequency of antimicrobial resistance among invasive and colonizing Group B streptococcal isolates. BMC Infect Dis 6:57
4. Gherardi G, Imperi M, Baldassarri L, Pataracchia M, Alfarone G, Recchia S, Orefici G, Dicuonzo G, Creti R (2007) Molecular epidemiology and distribution of serotypes, surface proteins, and antibiotic resistance among group B streptococci in Italy. J Clin Microbiolol 45:2909-2916 (Pubitemid 47421999)
5. Leclercq R (2002) Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications. Clin Infect Dis 34:482-492 (Pubitemid 34112269)
6. Arpin C, Daube H, Tessier F, Quentin C (1999) Presence of mefA and mefE genes in Streptococcus agalactiae. Antimicrob Agents Chemother 43:944-946 (Pubitemid 29165763)
7. Jones N, Bohnsack JF, Takahashi S, Oliver KA, Chan MS, Kunst F, Glaser P, Rusniok C, Crook DWM, Harding RM, Bisharat N, Spratt BG (2003) system for group B Streptococcus. J Clin Microbiol 41:2530-2536 (Pubitemid 36712464)
8. Slotved HC, Kong F, Lambertsen L, Sauer S, Gilbert GL (2007) Serotype IX, a proposed new Streptococcus agalactiae serotype. J Clin Microbiol 45:2929-2936 (Pubitemid 47417336)
9. Cieslewicz MJ, Chaffin D, Glusman G, Kasper D, Madan A, Rodrigues S, Fahey J, Wessels MR, Rubens CE (2005) Structural and genetic diversity of group B Streptococcus capsular polysaccharides. Infect Immun 73:3096-3103 (Pubitemid 40570379)
10. Sinha A, Lieu TA, Paoletti LC, Weinstein MC, Platt R (2005) The projected health benefits of maternal group B streptococcal vaccination in the era of chemoprophylaxis. Vaccine 23:3187- 3195
11. Gilbert GL (2004) Vaccines for other neonatal infections: are group B streptococcal infections vaccine-preventable? Expert Rev Vaccines 3:371-374 (Pubitemid 39061699)
12. Creti R, Fabretti F, Orefici G, von Hunolstein C (2004) Multiplex PCR assay for direct identification of group B streptococcal α- protein-like protein genes. J Clin Microbiol 42:1326-1329 (Pubitemid 38332881)
13. Lindahl G, Stålhammar-Carlemalm M, Areschoug T (2005) Surface proteins of Streptococcus agalactiae and related proteins in other bacterial pathogens. Clin Microbiol Rev 18:102-127 (Pubitemid 40170663)
14. Feil EJ, Li BC, Aanensen DM, Hanage WP, Spratt BG (2004) eBURST: inferring patterns of evolutionary descent among clusters of related bacterial genotypes from multilocus sequence typing data. J Bacteriol 186:1518-1530 (Pubitemid 38248742)
15. Bisharat N, Jones N, Marchaim D, Block C, Harding RM, Yagupsky P, Peto T, Crook DW (2005) Population structure of group B Streptococcus from a low-incidence region for invasive neonatal disease. Microbiology 151:1875-1881 (Pubitemid 40909030)
16. Clinical and Laboratory Standards Institute (CLSI) (2010) Performance standards for antimicrobial susceptibility testing, M100-S20 (2010), M02-A10 and M07-A8. CLSI, Wayne, PA
17. Gygax SE, Schuyler JA, Kimmel LE, Trama JP, Mordechai E, Adelson ME (2006) Erythromycin and clindamycin resistance in group B streptococcal clinical isolates. Antimicrob Agents Chemother 50:1875-1877
18. Sutcliffe JA, Grebe T, Tait-Kamradt A, Wondrack L (1996) Detection of erythromycin-resistant determinants by PCR. Antimicrob Agents Chemother 40:2562-2566 (Pubitemid 26367644)
19. De Azavedo JCS, Yeung RH, Bast DJ, Duncan CL, Borgia SB, Low DE (1999) Prevalence and mechanisms of macrolide resistance in clinical isolates of group A streptococci from Ontario, Canada. Antimicrob Agents Chemother 43:2144-2147 (Pubitemid 29421191)
20. Desjardins M, Delgaty KL, Ramotar K, Seetaram C, Toye B (2004) Prevalence and mechanisms of erythromycin resistance in group A and group B Streptococcus: implications for reporting susceptibility results. J Clin Microbiol 42:5620-5623 (Pubitemid 40003766)
21. Sadowy E, Matynia B, Hryniewicz W (2010) Population structure, virulence factors and resistance determinants of invasive, noninvasive and colonizing Streptococcus agalactiae in Poland. J Antimicrob Chemother 65:1907-1914
22. Brochet M, Couvé E, Zouine M, Vallaeys T, Rusniok C, Lamy MC, Buchrieser C, Trieu-Cuot P, Kunst F, Poyart C, Glaser P (2006) Genomic diversity and evolution within the species Streptococcus agalactiae. Microbes infect 8:1227-1243 (Pubitemid 43831687)
23. Quentin R, Huet H, Wang FS, Geslin P, Goudeau A, Selander RK (1995) Characterization of Streptococcus agalactiae strains by multilocus enzyme genotype and serotype: identification of multiple virulent clone families that cause invasive neonatal disease. J Clin Microbiol 33:2576-2581
24. Amin A, Abdulrazzaq YM, Uduman S (2002) Group B streptococcal serotype distribution of isolates from colonized pregnant women at the time of delivery in United Arab Emirates. J Infect 45:42-46 (Pubitemid 36104807)
25. Lachenauer CS, Kasper DL, Shimada J, Ichiman Y, Ohtsuka H, Kaku M, Paoletti LC, Ferrieri P, Madoff LC (1999) Serotypes VI and VIII predominate among group B streptococci isolated from pregnant Japanese women. J Infect Dis 179:1030-1033 (Pubitemid 29159354)
26. Diekema DJ, Andrews JI, Huynh H, Rhomberg PR, Doktor SR, Beyer J, Shortridge VD, Flamm RK, Jones RN, Pfaller MA (2003) Molecular epidemiology of macrolide resistance in neonatal bloodstream isolates of group B streptococci. J Clin Microbiol 41:2659- 2661 (Pubitemid 36712484)
27. Lin FY, Azimi PH, Weisman LE, Philips JB 3rd, Regan J, Clark P, Rhoads GG, Clemens J, Troendle J, Pratt E, Brenner RA, Gill V (2000) Antibiotic susceptibility profiles for group B streptococci isolated from neonates, 1995-1998. Clin Infect Dis 31:76-79 (Pubitemid 32268942)
28. von Both U, Ruess M, Mueller U, Fluegge K, Sander A, Berner R (2003) A serotype V clone is predominant among erythromycinresistant Streptococcus agalactiae isolates in a southwestern region of Germany. J Clin Microbiol 41:2166-2169 (Pubitemid 36576556)
29. Figueira-Coelho J, Ramirez M, Salgado MJ, Melo-Cristino J (2004) Streptococcus agalactiae in a large Portuguese teaching hospital: antimicrobial susceptibility, serotype distribution, and clonal analysis of macrolide-resistant isolates. Microb Drug Resist 10:31-36 (Pubitemid 38529714)
30. Florindo C, Viegas S, Paulino A, Rodrigues E, Gomes JP, Borrego MJ (2010) Molecular characterization and antimicrobial susceptibility profiles in Streptococcus agalactiae colonizing strains: association of erythromycin resistance with subtype III-1 genetic clone family. Clin Microbiol Infect 16(9):1458-1463
31. Fluegge K, Supper S, Siedler A, Berner R (2004) Antibiotic susceptibility in neonatal invasive isolates of Streptococcus agalactiae in a 2-year nationwide surveillance study in Germany. Antimicrob Agents Chemother 48:4444-6 (Pubitemid 39434912)
32. Gonzalez JJ, Andreu A; Spanish Group for the Study of Perinatal infection from the Spanish Society for Clinical Microbiology and Infectious Diseases (2005) Multicenter study of the mechanisms of resistance and clonal relationships of Streptococcus agalactiae isolates resistant to macrolides, lincosamides, and ketolides in Spain. Antimicrob Agents Chemother 49:2525-2527 (Pubitemid 40734496)
33. de Azavedo JC, McGavin M, Duncan C, Low DE, McGeer A (2001) Prevalence and mechanisms of macrolide resistance in invasive and noninvasive group B streptococcus isolates from Ontario, Canada. Antimicrob Agents Chemother 45:3504-3508 (Pubitemid 33107869)
34. Fitoussi F, Loukil C, Gros I, Clermont O, Mariani P, Bonacorsi S, Le Thomas I, Deforche D, Bingen E (2001) Mechanisms of macrolide resistance in clinical group B streptococci isolated in France. Antimicrob Agents Chemother 45:1889-1891 (Pubitemid 32466367)
35. Motlová J, Straková L, Urbásková P, Sak P, Sever T (2004) Vaginal and rectal carriage of Streptococcus agalactiae in the Czech Republic: incidence, serotypes distribution and susceptibility to antibiotics. Indian J Med Res 119:84-87 (Pubitemid 39004453)
36. Bronzwaer SL, Cars O, Buchholz U, Mölstad S, Goettsch W, Veldhuijzen IK, Kool JL, Sprenger MJ, Degener JE; European Antimicrobial Resistance Surveillance System (2002) A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerg Infect Dis 8:278-282 (Pubitemid 34266265)
37. Dahesh S, HenslerME, Van Sorge NM, Gertz RE Jr, Schrag S, Nizet V, Beall BW (2008) Point mutation in the group B streptococcal pbp2x gene conferring decreased susceptibility to β-lactam antibiotics. Antimicrob Agents Chemother 52:2915-2918
38. Kimura K, Suzuki S,Wachino J,KurokawaH, YamaneK, Shibata N, Nagano N, Kato H, Shibayama K, Arakawa Y (2008) First molecular characterization of group B streptococci with reduced penicillin susceptibility. Antimicrob Agents Chemother 52:2890-2897
39. Bingen E, Fitoussi F, Doit C, Cohen R, Tanna A, George R, Loukil C, Brahimi N, Le Thomas I, Deforche D (2000) Resistance to macrolides in Streptococcus pyogenes in France in pediatric patients. Antimicrob Agents Chemother 44:1453-1457 (Pubitemid 30340778)